Package Leaflet: Information for the user
Ditropan5 mg tablets
oxybutynin hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Ditropan belongs to a group of medicines called urinary antispasmodics.
This medicine works on the contractions of the bladder and delays the need to urinate. It can be used to treat some types of incontinence and other urinary problems.
Ditropan can be used in children aged 5 years and older to treat:
Read the following sections carefully:
Do not take Ditropan
Warnings and precautions
Consult your doctor or pharmacist before starting to take Ditropan.
Special care should be taken:
Elderly patients
Ditropan should be used with caution in elderly patients because they have a higher risk of experiencing adverse reactions and due to the risk of cognitive decline.
Children
Children under 5 years of age
The use of this medication is not recommended in children under 5 years of age.
Children aged 5 years and older
Children in this age group have a higher risk of experiencing adverse reactions to the product.
Other medicines and Ditropan
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
Ditropan may affect the absorption of concomitantly administered medications.
Especially, inform your doctor if you are currently taking any of the following medications:
Ditropan with alcohol
The simultaneous use of Ditropan and alcohol may increase somnolence.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
If you are pregnant or suspect you may be pregnant while taking Ditropan, you must inform your doctor immediately. It is recommended not to take this medicine during pregnancy, unless your doctor considers it necessary.
Breastfeeding
Ditropan passes into breast milk. The use of this medicine is not recommended during breastfeeding. If your doctor considers it necessary, breastfeeding will be interrupted.
Driving and using machines
Ditropan causes somnolence or blurred vision, so you should be careful when performing activities that require a state of mental alertness, such as driving, operating machinery, or performing hazardous work while using this medicine.
Abuse and dependence
Dependence on oxybutynin has been observed in patients with a history of substance abuse or dependence (see section 4).
Ditropan contains lactose
This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Ditropan contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per unit dose; it is essentially "sodium-free".
Follow the administration instructions of this medicine exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Dosage
Adults
The recommended dose in adults is 3 tablets (15 mg of oxybutynin hydrochloride) per day, divided into three doses, although they can also be taken together at the end of the day in case of nocturnal urinary problems. The dose can be increased to 4 tablets (20 mg of oxybutynin hydrochloride) per day and also reduced to a lower maintenance dose.
Use in children and adolescents
Children under 5 years of age
The safety and efficacy of Ditropan have not been established in children under 5 years of age.
Children aged 5 years and older
A dose of 2 tablets (10 mg of oxybutynin hydrochloride) per day is recommended. There should be at least 4 hours between each dose.
Elderly patients
In elderly patients, a dose of 2 tablets per day is usually sufficient.
If you think the effect of Ditropan is too strong or too weak, consult your doctor or pharmacist.
Method of administration
Remember to take your medicine. Ditropan should be taken regularly according to your doctor's instructions throughout the treatment.
Ditropan is indicated for oral use only.
The tablet should be swallowed whole or can be broken and taken with a large amount of liquid to ensure passage through the esophagus. The taste of the tablets is not pleasant.
If you take more Ditropan than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you have taken too much Ditropan, you may experience some symptoms, e.g., restlessness, excitement, psychotic behavior, flushing, decreased blood pressure, respiratory problems, paralysis, and coma.
If you forget to take Ditropan
In case of forgetting a dose, wait for the next one. Do not take a double dose to make up for the forgotten doses.
If you stop taking Ditropan
If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common side effects (may affect more than 1 in 10 people):
Dry mouth, constipation, nausea, dizziness, somnolence, blurred vision, difficulty urinating, dry skin, headache.
Common side effects (may affect up to 1 in 10 people):
Asthenia, diarrhea, vomiting, dysgeusia (disorder of taste), flatulence (gas), confusion, atrial arrhythmia, nodal arrhythmia, supraventricular extrasystole, strong heartbeats that can be rapid or irregular, dry eyes, urinary retention, hematuria (blood in the urine), nocturia (need to urinate at night), pyuria (presence of leukocytes in the urine), pharyngitis (inflammation of the pharynx), skin redness.
Uncommon side effects (may affect up to 1 in 100 people):
Abdominal discomfort, anorexia (loss of appetite), decreased appetite, dysphagia (difficulty swallowing), cough, epistaxis (nasal bleeding), vulvovaginitis (inflammation of the vulva and vagina).
Rare side effects (may affect up to 1 in 1,000 people):
Photosensitivity (sensitivity to light), thrombocytopenia (reduction in platelet count).
Frequency not known (cannot be estimated from the available data):
Gastroesophageal reflux, gastritis, pseudo-obstruction in at-risk patients (in elderly patients or patients with constipation and being treated with other medications that decrease intestinal motility), hallucinations, agitation, convulsions, anxiety, nightmares, paranoia (distrust, delusions), cognitive disorders, especially in elderly patients, symptoms of depression, and dependence on oxybutynin (in patients with a history of substance abuse or dependence), tachycardia (increased heart rate), arrhythmia, angle-closure glaucoma (increased intraocular pressure), mydriasis (pupil dilation), intraocular hypertension, urinary tract infection, adverse reactions such as generalized cutaneous erythema, urticaria, angioedema (generalized inflammation of feet, hands, throat, lips, and respiratory tract), skin rash, hypohidrosis (decreased sweat production), heat stroke, hypersensitivity, muscular disorders (pain, cramps, or weakness).
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Store in the original package. Store below 30 °C.
Do not use this medicine after the expiration date stated on the package after EXP. The expiration date is the last day of the month indicated.
Do not use this medicine if you notice that the tablets have a different appearance (e.g., if they change color).
Medicines should not be disposed of via wastewater or household waste. Return the packages and medicines you no longer need to the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Ditropan
Appearance of the product and contents of the pack
Ditropan is presented in the form of tablets. Each package contains 60 tablets. The tablets are round, biconvex, light blue in color with a central score line on one face and the engraving "OXB5" on the opposite face.
Marketing authorization holder and manufacturer
Marketing authorization holder
CHEPLAPHARM Arzneimittel GmbH
Ziegelhof 24
17489 Greifswald
Germany
Manufacturer
Sanofi Winthrop Industrie
Avenue Gustave Eiffel, 30-36
37100 Tours
France
or
Fidelio Healthcare Limburg GmbH
Mundipharmastraße 2
65549 Limburg an der Lahn
Germany
Local representative
Laboratorios Rubió, S.A.
Industria, 29
Pol. Ind. Comte de Sert
08755 Castellbisbal (Barcelona)
Spain
Other sources of information
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of DITROPAN 5 mg TABLETS in October, 2025 is around 4.15 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.